
Phase II Trial Shows Promise for Pre-Surgical PRRT in Pancreatic Neuroendocrine Tumors
Using PRRT with 177Lu-DOTATATE before surgery is both safe and effective for patients with non-functioning pancreatic neuroendocrine tumors and certain risk factors, according to the